Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
10.69
Dollar change
-0.12
Percentage change
-1.11
%
Index- P/E2.11 EPS (ttm)5.07 Insider Own31.18% Shs Outstand806.68M Perf Week2.10%
Market Cap7.90B Forward P/E- EPS next Y-1.12 Insider Trans-1.33% Shs Float508.37M Perf Month-7.04%
Income4.35B PEG- EPS next Q-0.24 Inst Own60.30% Short Float7.28% Perf Quarter5.42%
Sales124.80M P/S63.28 EPS this Y-120.01% Inst Trans2.84% Short Ratio5.61 Perf Half Y-1.11%
Book/sh7.40 P/B1.44 EPS next Y-6.76% ROA90.49% Short Interest37.00M Perf Year10.09%
Cash/sh8.85 P/C1.21 EPS next 5Y- ROE122.05% 52W Range8.24 - 13.24 Perf YTD-4.81%
Dividend Est.- P/FCF- EPS past 5Y0.08% ROI67.46% 52W High-19.26% Beta1.25
Dividend TTM- Quick Ratio25.10 Sales past 5Y493.24% Gross Margin74.95% 52W Low29.65% ATR (14)0.34
Dividend Ex-Date- Current Ratio25.24 EPS Y/Y TTM476.90% Oper. Margin-865.37% RSI (14)46.25 Volatility2.37% 3.27%
Employees908 Debt/Eq0.08 Sales Y/Y TTM103.65% Profit Margin3484.86% Recom1.17 Target Price16.68
Option/ShortYes / Yes LT Debt/Eq0.08 EPS Q/Q-315.45% Payout0.00% Rel Volume0.42 Prev Close10.81
Sales Surprise-6.70% EPS Surprise28.14% Sales Q/Q5.68% EarningsMay 30 BMO Avg Volume6.59M Price10.69
SMA20-1.52% SMA50-2.87% SMA2000.93% Trades Volume2,802,689 Change-1.11%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Outperform $17
Jan-05-24Initiated Piper Sandler Overweight $20
Dec-12-23Initiated Deutsche Bank Buy $14
Oct-17-23Initiated Guggenheim Buy $17
Jun-08-23Initiated BofA Securities Neutral $10.50
Oct-27-22Initiated JP Morgan Overweight $7
May-23-22Initiated SVB Leerink Outperform $6
Apr-29-22Initiated Cantor Fitzgerald Overweight $15
Dec-15-21Initiated Goldman Buy $15
Nov-08-21Initiated H.C. Wainwright Buy $14
May-31-24 08:04AM
May-30-24 11:53AM
08:20AM
07:00AM
May-27-24 06:28PM
06:13PM Loading…
06:13PM
May-16-24 04:05PM
May-08-24 02:43AM
May-07-24 02:04PM
May-01-24 10:47AM
Apr-25-24 08:00AM
Apr-12-24 11:09AM
Apr-02-24 07:00AM
Mar-27-24 01:55PM
Mar-26-24 06:22PM
08:50AM Loading…
Mar-17-24 08:50AM
Mar-14-24 07:04AM
Feb-15-24 02:45AM
Feb-13-24 07:00AM
Feb-10-24 02:55AM
Jan-30-24 04:05PM
Dec-27-23 08:05PM
Dec-20-23 04:30PM
Dec-14-23 09:00AM
Nov-28-23 07:00AM
02:38AM
Nov-27-23 08:00AM
Nov-14-23 01:00PM
Nov-13-23 07:00AM
Nov-10-23 08:00AM
05:30PM Loading…
Oct-30-23 05:30PM
Oct-24-23 08:00AM
Oct-23-23 03:02PM
10:31AM
09:52AM
06:55AM
03:49AM
01:00AM
Oct-13-23 08:00AM
Oct-05-23 05:01AM
Oct-03-23 07:00AM
Sep-30-23 05:00AM
Sep-26-23 06:00AM
Sep-11-23 08:00AM
Sep-09-23 10:51AM
Aug-17-23 04:05PM
Aug-14-23 07:00AM
Aug-03-23 04:05PM
Aug-02-23 04:05PM
Jul-27-23 08:00AM
Jul-26-23 10:21AM
Jul-13-23 05:50PM
Jul-11-23 08:00AM
Jun-28-23 08:57AM
07:00AM
Jun-26-23 04:05PM
Jun-22-23 07:30AM
Jun-21-23 05:00PM
May-16-23 07:00AM
Apr-04-23 07:37AM
07:37AM
Mar-28-23 08:00AM
Mar-15-23 07:45AM
Mar-14-23 04:07PM
08:00AM
Mar-07-23 08:00AM
Feb-21-23 08:32PM
Feb-13-23 04:17PM
07:00AM
Feb-02-23 09:14PM
Feb-01-23 04:05PM
Jan-30-23 08:00AM
Jan-04-23 06:05AM
Dec-07-22 06:30AM
Dec-01-22 08:00AM
Nov-14-22 07:00AM
Nov-10-22 09:00AM
Nov-08-22 06:15AM
Nov-07-22 04:01PM
Oct-18-22 04:00PM
Aug-30-22 07:00AM
Aug-16-22 11:44AM
Aug-15-22 07:00AM
Aug-14-22 10:53AM
Aug-03-22 07:00AM
Jul-23-22 09:00AM
Jun-30-22 09:18AM
Jun-28-22 06:27AM
06:10AM
06:00AM
Jun-15-22 04:30PM
May-24-22 06:00AM
May-19-22 04:30PM
May-16-22 07:00AM
May-09-22 11:16AM
May-02-22 07:00AM
Apr-20-22 07:00AM
Apr-13-22 07:00AM
Mar-25-22 08:01AM
Mar-24-22 07:00AM
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Venker EricPresident & COOFeb 09 '24Option Exercise3.8596,950373,258629,157Feb 09 09:00 PM
Venker EricPresident & COOFeb 09 '24Sale10.9296,9501,058,694532,207Feb 09 09:00 PM
Ramaswamy Vivek10% OwnerJan 02 '24Sale11.053,000,00033,150,00051,929,426Jan 03 04:56 PM
Venker EricChief Operating OfficerOct 05 '23Sale10.11153,0271,547,103595,397Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 04 '23Option Exercise3.85153,027589,154748,424Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 03 '23Option Exercise3.85606,2212,333,9511,201,618Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 03 '23Sale10.25606,2216,213,765595,397Oct 04 09:30 PM
Venker EricChief Operating OfficerOct 02 '23Option Exercise3.85440,7521,696,8951,036,149Oct 04 09:30 PM
Roivant Sciences Ltd.DirectorOct 02 '23Buy38.001,526,31658,000,00879,805,331Oct 04 05:15 PM
Venker EricChief Operating OfficerOct 02 '23Sale10.80440,7524,760,122595,397Oct 04 09:30 PM
SVF Investments (UK) Ltd10% OwnerSep 28 '23Sale12.6010,000,000126,000,00073,031,667Oct 02 09:00 PM
QVT Financial LPDirector by DeputizationSep 28 '23Sale11.5510,000,000115,500,000100,804Oct 02 08:43 PM
Gold Daniel AllenDirectorSep 28 '23Sale11.5510,000,000115,500,000100,804Oct 02 08:55 PM
MANCHESTER KEITH SDirectorSep 28 '23Sale11.556,896,14479,650,4635,023,787Oct 02 09:05 PM
Venker EricPresident & COOSep 27 '23Option Exercise3.85500,0001,925,0001,095,397Sep 29 09:30 PM
Venker EricPresident & COOSep 27 '23Sale13.02500,0006,510,000595,397Sep 29 09:30 PM
Kumar RakhiChief Accounting OfficerSep 08 '23Option Exercise6.4899,350643,788297,300Sep 12 09:30 PM
Venker EricChief Operating OfficerSep 08 '23Option Exercise3.85106,430409,756718,243Sep 12 09:32 PM
Venker EricChief Operating OfficerSep 08 '23Sale12.19106,4301,297,382611,813Sep 12 09:32 PM
Kumar RakhiChief Accounting OfficerSep 08 '23Sale12.1899,3501,210,083197,950Sep 12 09:30 PM
Venker EricChief Operating OfficerSep 06 '23Option Exercise3.855,92622,815617,739Sep 06 09:30 PM
Venker EricChief Operating OfficerSep 06 '23Sale11.855,92670,223611,813Sep 06 09:30 PM
Venker EricChief Operating OfficerSep 05 '23Option Exercise3.8573,275282,109685,088Sep 06 09:30 PM
Kumar RakhiChief Accounting OfficerSep 05 '23Option Exercise6.481,72411,172199,674Sep 07 09:30 PM
Venker EricChief Operating OfficerSep 05 '23Sale11.9273,275873,438611,813Sep 06 09:30 PM
Kumar RakhiChief Accounting OfficerSep 05 '23Sale12.001,72420,688197,950Sep 07 09:30 PM
Venker EricChief Operating OfficerSep 01 '23Option Exercise3.8514,76356,838626,576Sep 06 09:30 PM
Venker EricChief Operating OfficerSep 01 '23Sale11.9014,763175,680611,813Sep 06 09:30 PM
Venker EricChief Operating OfficerAug 14 '23Option Exercise3.8559,811230,272687,729Aug 16 09:34 PM
Venker EricChief Operating OfficerAug 14 '23Sale11.8959,811711,153627,918Aug 16 09:34 PM
Venker EricChief Operating OfficerAug 03 '23Option Exercise3.8544,629171,822672,547Aug 07 09:30 PM
Kumar RakhiChief Accounting OfficerAug 03 '23Option Exercise6.483,68123,853203,009Aug 03 09:30 PM
Venker EricChief Operating OfficerAug 03 '23Sale11.9344,629532,424627,918Aug 07 09:30 PM
Kumar RakhiChief Accounting OfficerAug 03 '23Sale12.003,68144,172199,328Aug 03 09:30 PM
Venker EricChief Operating OfficerAug 02 '23Option Exercise3.8516,39763,128644,315Aug 02 09:30 PM
Venker EricChief Operating OfficerAug 02 '23Sale11.8616,397194,468627,918Aug 02 09:30 PM
Venker EricChief Operating OfficerAug 01 '23Option Exercise3.8561,397236,378689,315Aug 02 09:30 PM
Kumar RakhiChief Accounting OfficerAug 01 '23Option Exercise6.483362,177199,664Aug 03 09:30 PM
Venker EricChief Operating OfficerAug 01 '23Sale11.9261,397731,852627,918Aug 02 09:30 PM
Kumar RakhiChief Accounting OfficerAug 01 '23Sale12.003364,032199,328Aug 03 09:30 PM
Venker EricChief Operating OfficerJul 31 '23Option Exercise3.85117,372451,882745,290Aug 02 09:30 PM
Venker EricChief Operating OfficerJul 31 '23Sale11.91117,3721,397,901627,918Aug 02 09:30 PM
Venker EricChief Operating OfficerJul 27 '23Option Exercise3.8523,62290,945651,540Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 27 '23Sale10.9823,622259,370627,918Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 26 '23Option Exercise3.8573,568283,237701,486Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 26 '23Sale10.9173,568802,627627,918Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 25 '23Option Exercise3.8528,344109,124656,262Jul 27 09:30 PM
Venker EricChief Operating OfficerJul 25 '23Sale10.8628,344307,816627,918Jul 27 09:30 PM
Venker EricPresident & COOJul 24 '23Option Exercise3.8533,081127,362677,296Jul 24 09:31 PM
Venker EricPresident & COOJul 24 '23Sale10.9333,081361,575644,215Jul 24 09:31 PM
Venker EricPresident & COOJul 21 '23Option Exercise3.85181,998700,692826,213Jul 24 09:31 PM
Venker EricPresident & COOJul 21 '23Sale11.13181,9982,025,638644,215Jul 24 09:31 PM
Venker EricPresident & COOJul 20 '23Option Exercise3.85159,387613,640803,602Jul 24 09:31 PM
Venker EricPresident & COOJul 20 '23Sale11.31159,3871,802,667644,215Jul 24 09:31 PM
Kumar RakhiChief Accounting OfficerJul 18 '23Option Exercise6.4810064882,228Jul 18 09:30 PM
Kumar RakhiChief Accounting OfficerJul 18 '23Sale12.001001,20082,128Jul 18 09:30 PM
Kumar RakhiChief Accounting OfficerJul 14 '23Option Exercise6.485353,46782,663Jul 18 09:30 PM
Kumar RakhiChief Accounting OfficerJul 14 '23Sale12.005356,42082,128Jul 18 09:30 PM
Sumitomo Chemical Co., Ltd.10% OwnerJun 22 '23Sale8.6015,116,277129,999,98271,251,083Jun 26 04:05 PM
VIKING GLOBAL PERFORMANCE LLC10% OwnerJun 22 '23Sale9.9013,000,000128,700,000641,010Jun 26 05:10 PM
VIKING GLOBAL INVESTORS LP10% OwnerJun 22 '23Sale9.9013,000,000128,700,000641,010Jun 26 05:11 PM